Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
50.41
-1.43 (-2.75%)
Mar 13, 2026, 3:49 PM EDT - Market open
Maze Therapeutics Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$55.57
Upside
+10.24%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Initiates $97 | Buy | Initiates | $97 | +92.42% | Mar 10, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $46 | Strong Buy | Reiterates | $46 | -8.75% | Mar 9, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $46 → $58 | Strong Buy | Maintains | $46 → $58 | +15.06% | Mar 4, 2026 |
| BTIG | BTIG | Strong Buy Maintains $37 → $46 | Strong Buy | Maintains | $37 → $46 | -8.75% | Jan 16, 2026 |
| Wells Fargo | Wells Fargo | Buy Initiates $55 | Buy | Initiates | $55 | +9.11% | Dec 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $60 | Strong Buy | Maintains | $50 → $60 | +19.02% | Dec 3, 2025 |
| Wedbush | Wedbush | Buy Maintains $35 → $36 | Buy | Maintains | $35 → $36 | -28.59% | Nov 7, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $27 → $37 | Buy | Maintains | $27 → $37 | -26.60% | Sep 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | -0.81% | Sep 18, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $19 → $34 | Strong Buy | Maintains | $19 → $34 | -32.55% | Sep 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $34 → $50 | Strong Buy | Maintains | $34 → $50 | -0.81% | Sep 12, 2025 |
| BTIG | BTIG | Strong Buy Maintains $30 → $37 | Strong Buy | Maintains | $30 → $37 | -26.60% | Sep 12, 2025 |
| BTIG | BTIG | Strong Buy Maintains $30 → $37 | Strong Buy | Maintains | $30 → $37 | -26.60% | Sep 11, 2025 |
| BTIG | BTIG | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | -40.49% | Sep 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $34 | Strong Buy | Initiates | $34 | -32.55% | Jul 23, 2025 |
| Wedbush | Wedbush | Buy Initiates $17 | Buy | Initiates | $17 | -66.28% | Jul 8, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.